Abbott India Limited vs Sobha Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and Sobha Limited (Real estate development) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Abbott India Limited leads on Revenue (approx.).
Abbott India Limited leads on Revenue (approx.).
The right choice depends on whether the buyer prioritizes pharmaceuticals or real estate exposure. Choose Abbott India if you want a company with strong parentage, recognized branded formulations, and an established doctor and pharmacy network, while accepting domestic-market concentration and price-control exposure. Choose Sobha if you want exposure to premium residential real estate with integrated execution capabilities and a strong Bengaluru-led presence, while accepting cyclical demand, funding needs, and regulatory delays.
Grounded in the verified figures and SWOT shown — guidance, not investment advice.
Head-to-head highlights
| Metric | Abbott India Limited | Sobha Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | Approximately INR 3,000-4,000 crore | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
Sobha Limited
Real estate development · India
Sobha Limited is an Indian real estate developer focused primarily on residential projects, with additional exposure to commercial development and contractual construction. The company is known for integrated in-house capabilities across design, engineering, construction, and interiors.
Verified financials
No source-verified financials available.
Strengths
- Strong brand reputation in premium residential real estate
- Integrated construction and design capabilities
- Established presence in Bengaluru and select high-demand markets
- Track record of project execution
Weaknesses
- High dependence on cyclical real estate demand
- Capital-intensive business with ongoing funding needs
- Geographic concentration compared with some larger peers
- Exposure to regulatory and approval delays
Opportunities
- Rising demand for premium and luxury housing in Indian cities
- Expansion into new urban growth corridors
- Improved affordability from income growth and mortgage penetration
- Potential monetization of land bank and commercial assets
Threats
- Interest rate increases affecting housing affordability
- Competition from larger national developers
- Construction cost inflation
- Delays in land acquisition, approvals, or project execution
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs Sobha Limited: which company leads overall?
Abbott India Limited leads on Revenue (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
Global Proptech & Smart Buildings Market — Intelligence Report
Philippines Facility Management Market — Intelligence Report
Global High-Density Compute Data Center Modular Construction, Site Selection & Permitting Market — Intelligence Report
Global Digital Payments & Real-Time Rails Market — Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs Sobha Limited's verified data. Modeled estimates — not investment advice.
- Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories.
- Abbott India markets branded prescription and over-the-counter healthcare products across areas including gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
- Sobha Limited is an Indian real estate developer focused primarily on residential projects, with additional exposure to commercial development and contractual construction.
- Notable point: The two companies operate in different Indian industries, with Abbott India in pharmaceuticals and Sobha Limited in real estate development.